Silverarc Capital Management’s LAVA Therapeutics LVTX Stock Holding History

Silverarc Capital Management’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-140,291	Closed	-$233K	–	92
2023 Q1	$233K	Sell	140,291 -297,471	-68%	-$833K	0.1%	68
2022 Q4	$1.53M	Sell	437,762 -173,047	-28%	-$794K	0.53%	57
2022 Q3	$2.79M	Buy	+610,809	New	+$1.68M	1.18%	37

Other funds holding LVTX

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $26B AUM 58.22% 1-Year Est. Return